Ha Tay Pharmaceutical JSC (HNX:DHT)

Vietnam · Delayed Price · Currency is VND

56,600

+100 (0.18%)

At close: Aug 28, 2026

-27.60% (1Y)

Market Cap	5.13T -27.6%
Revenue (ttm)	2.48T +14.8%
Net Income	40.16B -44.9%
EPS	443.40 -44.9%
Shares Out	90.57M
PE Ratio	127.65
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,900
Open	56,000
Previous Close	56,500
Day's Range	55,400 - 57,400
52-Week Range	54,400 - 86,800
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, pharmaceutical chemicals, and cosmetics and medical equipment primarily in Vietnam. The company provides medical material, medicinal food, and hygiene products. It also engages in the real estate; and land use rights owned, used, or leased businesses. In addition, the company produces and sells functional food products; and engages in wholesale of food products, as well as contract manufacturing services for pharmaceutical and functional food products. The compan... [Read more]

Industry Pharmaceutical Preparations

Founded 1965

Employees 586

Stock Exchange Hanoi Stock Exchange

Ticker Symbol DHT

Full Company Profile

Financial Performance

In 2025, Ha Tay Pharmaceutical JSC's revenue was 2.40 trillion, an increase of 15.13% compared to the previous year's 2.09 trillion. Earnings were 53.66 billion, a decrease of -25.24%.

Financial Statements